Acute kidney injury (AKI) is associated with several adverse outcomes, including new or progressive chronic kidney disease, end-stage kidney disease, and mortality. Epidemiological studies have reported an association between AKI and dementia as a long-term adverse outcome. This meta-analysis was aimed to understand the association between AKI and dementia risk. A literature search was performed in MEDLINE and Embase databases, from inception to July 2021, to identify epidemiological studies reporting the association between AKI and dementia risk. Title and abstract followed by the full-text of retrieved articles were screened, data were extracted, and quality was assessed, using the Newcastle-Ottawa scale by two investigators independently. The primary outcome was to compute the pooled risk of dementia in AKI patients. Subgroup analysis was also performed based on age and co-morbidities. Certainty of evidence was assessed using the GRADE approach. Statistical analysis was performed using Review Manager 5.4 software. Four studies (cohort (n = 3) and case-control (n = 1)) with a total of 429,211 patients, of which 211,749 had AKI, were identified. The mean age of the patients and the follow-up period were 64.15 ± 16.09 years and 8.9 years, respectively. Included studies were of moderate to high quality. The pooled estimate revealed a significantly higher risk of dementia in AKI patients with an overall relative risk/risk ratio (RR) of 1.92 (95% CI: 1.52-2.43), p ≤ 0.00001. Dementia risk increases by 10% with one year increase in age with an RR of 1.10 (95% CI: 1.09-1.11), p < 0.00001. Subgroup analysis based on stroke as a co-morbid condition also revealed significantly higher dementia risk in AKI patients (RR 2.30 (95% CI: 1.62-3.28), p = 0.009). All-cause mortality risk was also significantly higher in AKI patients with dementia with a pooled RR of 2.11 (95% CI: 1.20-3.70), p = 0.009. The strength of the evidence was of very low certainty as per the GRADE assessment. Patients with AKI have a higher risk of dementia. Further large epidemiological studies are needed to confirm the mechanistic association.

Czech National Centre for Evidence Based Healthcare and Knowledge Translation Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Division of Nephrology Hospital Obrero No 2 CNS Cochabamba Bolivia

Menzies Institute for Medical Research University of Tasmania 17 Liverpool Street Hobart TAS 7000 Australia

Universidad Mayor de San Simon School of Medicine Cochabamba Bolivia

See more in PubMed

Levey A.S., Levin A., Kellum J.A. Definition and classification of kidney diseases. Am. J. Kidney Dis. 2013;61:686–688. doi: 10.1053/j.ajkd.2013.03.003. PubMed DOI

Lameire N.H., Bagga A., Cruz D., De Maeseneer J., Endre Z., Kellum J.A., Liu K.D., Mehta R.L., Pannu N., Biesen W.V. Acute kidney injury: An increasing global concern. Lancet. 2013;382:170–179. doi: 10.1016/S0140-6736(13)60647-9. PubMed DOI

Luyckx V.A., Tonelli M., Stanifer J.W. The global burden of kidney disease and the sustainable development goals. Bull. World Health Organ. 2018;96:414. doi: 10.2471/BLT.17.206441. PubMed DOI PMC

Hoste E.A.J., Kellum J.A., Selby N.M., Zarbock A., Palevsky P.M., Bagshaw S.M., Goldstein S.L., Cerdá J., Chawla L.S. Global epidemiology and outcomes of acute kidney injury. Nat. Rev. Nephrol. 2018;14:607–625. doi: 10.1038/s41581-018-0052-0. PubMed DOI

Grams M.E., Rabb H. The distant organ effects of acute kidney injury. Kidney Int. 2012;81:942–948. doi: 10.1038/ki.2011.241. PubMed DOI

Fortrie G., de Geus H.R., Betjes M.G. The aftermath of acute kidney injury: A narrative review of long-term mortality and renal function. Crit. Care. 2019;23:1–11. doi: 10.1186/s13054-019-2314-z. PubMed DOI PMC

Crowson C.S., Liao K.P., Davis J.M., III, Solomon D.H., Matteson E.L., Knutson K.L., Hlatky M.A., Gabriel S.E. Rheumatoid arthritis and cardiovascular disease. Am. Heart J. 2013;166:622–628.e1. doi: 10.1016/j.ahj.2013.07.010. PubMed DOI PMC

Cioffi G., Ognibeni F., Dalbeni A., Giollo A., Orsolini G., Gatti D., Rossini M., Viapiana O. High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis. Clin. Cardiol. 2018;41:736–743. doi: 10.1002/clc.22926. PubMed DOI PMC

Ungprasert P., Srivali N., Kittanamongkolchai W. Risk of incident atrial fibrillation in patients with rheumatoid arthritis: A systematic review and meta-analysis. Int. J. Rheum. Dis. 2017;20:434–441. doi: 10.1111/1756-185X.12820. PubMed DOI

Uzun S., Kozumplik O., Folnegović-Šmalc V. Alzheimer’s dementia: Current data review. Coll. Antropol. 2011;35:1333–1337. PubMed

WHO Dementia. [(accessed on 25 August 2021)]. Available online: https://www.who.int/news-room/fact-sheets/detail/dementia.

Nichols E., Szoeke C.E.I., Vollset S.E., Abbasi N., Abd-Allah F., Abdela J., Aichour M.T.E., Akinyemi R.O., Alahdab F., Asgedom S.W. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:88–106. doi: 10.1016/S1474-4422(18)30403-4. PubMed DOI PMC

Duggan S., Blackman T., Martyr A., Van Schaik P. The impact of early dementia on outdoor life: Ashrinking world’? Dementia. 2008;7:191–204. doi: 10.1177/1471301208091158. DOI

Norton S., Matthews F.E., Barnes D.E., Yaffe K., Brayne C. Potential for primary prevention of Alzheimer’s disease: An analysis of population-based data. Lancet Neurol. 2014;13:788–794. doi: 10.1016/S1474-4422(14)70136-X. PubMed DOI

Plassman B.L., Williams J.W., Jr., Burke J.R., Holsinger T., Benjamin S. Systematic review: Factors associated with risk for and possible prevention of cognitive decline in later life. Ann. Intern. Med. 2010;153:182–193. doi: 10.7326/0003-4819-153-3-201008030-00258. PubMed DOI

Schiffrin E.L., Lipman M.L., Mann J.F. Chronic kidney disease: Effects on the cardiovascular system. Circulation. 2007;116:85–97. doi: 10.1161/CIRCULATIONAHA.106.678342. PubMed DOI

Tamura M.K., Yaffe K. Dementia and cognitive impairment in ESRD: Diagnostic and therapeutic strategies. Kidney Int. 2011;79:14–22. doi: 10.1038/ki.2010.336. PubMed DOI PMC

Etgen T., Chonchol M., Förstl H., Sander D. Chronic kidney disease and cognitive impairment: A systematic review and meta-analysis. Am. J. Nephrol. 2012;35:474–482. doi: 10.1159/000338135. PubMed DOI

Bugnicourt J.-M., Godefroy O., Chillon J.-M., Choukroun G., Massy Z.A. Cognitive disorders and dementia in CKD: The neglected kidney-brain axis. J. Am. Soc. Nephrol. 2013;24:353–363. doi: 10.1681/ASN.2012050536. PubMed DOI

Kalaria R.N., Maestre G.E., Arizaga R., Friedland R.P., Galasko D., Hall K., Luchsinger J.A., Ogunniyi A., Perry E.K., Potocnik F. Alzheimer’s disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurol. 2008;7:812–826. doi: 10.1016/S1474-4422(08)70169-8. PubMed DOI PMC

Deckers K., Camerino I., van Boxtel M.P., Verhey F.R., Irving K., Brayne C., Kivipelto M., Starr J.M., Yaffe K., de Leeuw P.W. Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies. Neurology. 2017;88:198–208. doi: 10.1212/WNL.0000000000003482. PubMed DOI PMC

Liu M., Liang Y., Chigurupati S., Lathia J.D., Pletnikov M., Sun Z., Crow M., Ross C.A., Mattson M.P., Rabb H. Acute kidney injury leads to inflammation and functional changes in the brain. J. Am. Soc. Nephrol. 2008;19:1360–1370. doi: 10.1681/ASN.2007080901. PubMed DOI PMC

Verma S.K., Molitoris B.A. Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin. Nephrol. 2015;35:96–107. doi: 10.1016/j.semnephrol.2015.01.010. PubMed DOI PMC

Kendrick J., Holmen J., Srinivas T., You Z., Chonchol M., Jovanovich A. Acute kidney injury is associated with an increased risk of dementia. Kidney Int. Rep. 2019;4:1491. doi: 10.1016/j.ekir.2019.07.012. PubMed DOI PMC

Tsai H.-H., Yen R.-F., Lin C.-L., Kao C.-H. Increased risk of dementia in patients hospitalized with acute kidney injury: A nationwide population-based cohort study. PLoS ONE. 2017;12:e0171671. PubMed PMC

Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Moher D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. PubMed DOI PMC

Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., Thacker S.B. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012. doi: 10.1001/jama.283.15.2008. PubMed DOI

Hussain S., Singh A., Antony B.S.E., Kulgarova J., Licenik R., Klugar M. Association of acute kidney injury with the risk of dementia: A meta-analysis protocol. medRxiv. 2021 doi: 10.1101/2021.07.27.21261192. PubMed DOI PMC

Hussain S., Singh A., Zameer S., Jamali M.C., Baxi H., Rahman S.O., Alam M., Altamish M., Singh A.K., Anil D., et al. No association between proton pump inhibitor use and risk of dementia: Evidence from a meta-analysis. J. Gastroenterol. Hepatol. 2020;35:19–28. doi: 10.1111/jgh.14789. PubMed DOI

GRADE Working Group Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490. doi: 10.1136/bmj.328.7454.1490. PubMed DOI PMC

Shi F., Sun L., Kaptoge S. Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis. Atherosclerosis. 2021;320:70–78. doi: 10.1016/j.atherosclerosis.2021.01.018. PubMed DOI PMC

Higgins J.P., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons; Hoboken, NJ, USA: 2019.

Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557. PubMed DOI PMC

Singh A., Hussain S., Najmi A.K. Number of studies, heterogeneity, generalisability, and the choice of method for meta-analysis. J. Neurol. Sci. 2017;381:347. doi: 10.1016/j.jns.2017.09.026. PubMed DOI

GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University. Evidence Prime, Inc.; Hamilton, ON, Canada: 2020. [(accessed on 25 August 2021)]. Available online: https://gradepro.org.

Kao C.-C., Wu C.-H., Lai C.-F., Huang T.-M., Chen H.-H., Wu V.-C., Chen L., Wu M.-S., Wu K.-D., The NSARF Group Long-term risk of dementia following acute kidney injury: A population-based study. Tzu-Chi Med. J. 2017;29:201. PubMed PMC

Wu Y. Dementia as an independent risk factor for acute kidney injury in elderly patients: A propensity-score matching study. Nephrology. 2020;25:24.

See E.J., Jayasinghe K., Glassford N., Bailey M., Johnson D.W., Polkinghorne K.R., Toussaint N.D., Bellomo R. Long-term risk of adverse outcomes after acute kidney injury: A systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int. 2019;95:160–172. doi: 10.1016/j.kint.2018.08.036. PubMed DOI

Bedford M., Farmer C., Levin A., Ali T., Stevens P. Acute kidney injury and CKD: Chicken or egg? Am. J. Kidney Dis. 2012;59:485–491. doi: 10.1053/j.ajkd.2011.09.010. PubMed DOI

CKD increases risk of acute kidney injury during hospitalization. [(accessed on 25 August 2021)];Nat. Clin. Pract. Nephrol. 2008 4:408. doi: 10.1038/ncpneph0850. Available online: https://www.nature.com/articles/ncpneph0850#citeas. DOI

Chen T.-B., Yiao S.-Y., Sun Y., Lee H.-J., Yang S.-C., Chiu M.-J., Chen T.-F., Lin K.-N., Tang L.-Y., Lin C.-C. Comorbidity and dementia: A nationwide survey in Taiwan. PLoS ONE. 2017;12:e0175475. doi: 10.1371/journal.pone.0175475. PubMed DOI PMC

Peters R., Booth A., Rockwood K., Peters J., D’Este C., Anstey K.J. Combining modifiable risk factors and risk of dementia: A systematic review and meta-analysis. BMJ Open. 2019;9:e022846. doi: 10.1136/bmjopen-2018-022846. PubMed DOI PMC

Bunn F., Burn A.-M., Goodman C., Rait G., Norton S., Robinson L., Schoeman J., Brayne C. Comorbidity and dementia: A scoping review of the literature. BMC Med. 2014;12:1–15. doi: 10.1186/s12916-014-0192-4. PubMed DOI PMC

Zijlstra L.E., Trompet S., Mooijaart S.P., van Buren M., Sattar N., Stott D.J., Jukema J.W. The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: A longitudinal data analysis. BMC Nephrol. 2020;21:1–10. doi: 10.1186/s12882-020-01745-5. PubMed DOI PMC

Yaffe K., Ackerson L., Tamura M.K., Le Blanc P., Kusek J.W., Sehgal A.R., Cohen D., Anderson C., Appel L., DeSalvo K. Chronic kidney disease and cognitive function in older adults: Findings from the chronic renal insufficiency cohort cognitive study. J. Am. Geriatr. Soc. 2010;58:338–345. doi: 10.1111/j.1532-5415.2009.02670.x. PubMed DOI PMC

Hailpern S.M., Melamed M.L., Cohen H.W., Hostetter T.H. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III) J. Am. Soc. Nephrol. 2007;18:2205–2213. doi: 10.1681/ASN.2006101165. PubMed DOI

Hiramatsu R., Iwagami M., Nitsch D. Association between chronic kidney disease and incident diagnosis of dementia in England: A cohort study in Clinical Practice Research Datalink. BMJ Open. 2020;10:e033811. doi: 10.1136/bmjopen-2019-033811. PubMed DOI PMC

Fleegal-DeMotta M.A., Doghu S., Banks W.A. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J. Cereb. Blood Flow Metab. 2009;29:640–647. doi: 10.1038/jcbfm.2008.158. PubMed DOI

Bernardo-Castro S., Sousa J.A., Brás A., Cecília C., Rodrigues B., Almendra L., Machado C., Santo G., Silva F., Ferreira L. Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery. Front. Neurol. 2020;11:1605. doi: 10.3389/fneur.2020.594672. PubMed DOI PMC

Malek M. Brain consequences of acute kidney injury: Focusing on the hippocampus. Kidney Res. Clin. Pract. 2018;37:315. doi: 10.23876/j.krcp.18.0056. PubMed DOI PMC

Nongnuch A., Panorchan K., Davenport A. Brain–kidney crosstalk. Crit. Care. 2014;18:1–11. doi: 10.1186/cc13907. PubMed DOI PMC

Nie S., Feng Z., Tang L., Wang X., He Y., Fang J., Li S., Yang Y., Mao H., Jiao J. Risk factor analysis for AKI including laboratory indicators: A Nationwide multicenter study of hospitalized patients. Kidney Blood Press. Res. 2017;42:761–773. doi: 10.1159/000484234. PubMed DOI

Mogi M., Horiuchi M. Clinical interaction between brain and kidney in small vessel disease. Cardiol. Res. Pract. 2011;2011 doi: 10.4061/2011/306189. PubMed DOI PMC

Sutton T.A., Fisher C.J., Molitoris B.A. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 2002;62:1539–1549. doi: 10.1046/j.1523-1755.2002.00631.x. PubMed DOI

Kuźma E., Lourida I., Moore S.F., Levine D.A., Ukoumunne O.C., Llewellyn D.J. Stroke and dementia risk: A systematic review and meta-analysis. Alzheimer’s Dement. J. Alzheimer’s Assoc. 2018;14:1416–1426. doi: 10.1016/j.jalz.2018.06.3061. PubMed DOI PMC

Chertow G.M., Lazarus J.M., Paganini E.P., Allgren R.L., Lafayette R.A., Sayegh M.H. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J. Am. Soc. Nephrol. 1998;9:692–698. doi: 10.1681/ASN.V94692. PubMed DOI

Taudorf L., Nørgaard A., Brodaty H., Laursen T.M., Waldemar G. Dementia increases mortality beyond effects of comorbid conditions: A national registry-based cohort study. Eur. J. Neurol. 2021;28:2174–2184. doi: 10.1111/ene.14875. PubMed DOI PMC

Taudorf L., Nørgaard A., Waldemar G., Laursen T.M. Mortality in Dementia from 1996 to 2015: A National Registry-Based Cohort Study. J. Alzheimer’s Dis. 2021;79:289–300. doi: 10.3233/JAD-200823. PubMed DOI PMC

Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis

Association of Acute Kidney Injury with the Risk of Dementia: A Meta-Analysis